These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 15097810)
1. Bone lesion detection with carrier-added 99mTc-EDTMP in comparison with 99mTc-DPD. Fueger BJ; Mitterhauser M; Wadsak W; Ofluoglu S; Traub T; Karanikas G; Dudczak R; Pirich C Nucl Med Commun; 2004 Apr; 25(4):361-5. PubMed ID: 15097810 [TBL] [Abstract][Full Text] [Related]
2. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases. Pauwels EK; Blom J; Camps JA; Hermans J; Rijke AM Eur J Nucl Med; 1983; 8(3):118-22. PubMed ID: 6220908 [TBL] [Abstract][Full Text] [Related]
3. 99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. A visual and quantitative comparison. Lantto T; Vorne M; Mokka R; Vähätalo S Acta Radiol; 1987; 28(5):631-3. PubMed ID: 2960361 [TBL] [Abstract][Full Text] [Related]
4. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP. Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459 [TBL] [Abstract][Full Text] [Related]
5. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography). Ghiron J; Volkert WA; Garlich J; Holmes RA Int J Rad Appl Instrum B; 1991; 18(2):235-40. PubMed ID: 2026500 [TBL] [Abstract][Full Text] [Related]
6. A clinical comparison of 99mTc-DPD and two 99mTc-MDP agents. Vorne M; Vähätalo S; Lantto T Eur J Nucl Med; 1983; 8(9):395-7. PubMed ID: 6226527 [TBL] [Abstract][Full Text] [Related]
7. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions. Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350 [TBL] [Abstract][Full Text] [Related]
8. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication. Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the kinetics of methylene-diphosphonate (MDP) and dicarboxypropan-diphosphonic acid (DPD), two radio-diagnostics for bone scintigraphy. Schroth HJ; Hausinger F; Garth H; Oberhausen E Eur J Nucl Med; 1984; 9(12):529-32. PubMed ID: 6526051 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effect of 99mTc-DPD and 99mTc-MDP on experimentally-induced osteoarthritis in the stifle joint of the dog. Lee JY; Lee WG; Kim JH; Kang SS; Bae CS; Koong SS; Choi SH In Vivo; 2005; 19(4):781-5. PubMed ID: 15999549 [TBL] [Abstract][Full Text] [Related]
12. Samarium-153-EDTMP in bone metastases. Ahonen A; Joensuu H; Hiltunen J; Hannelin M; Heikkilä J; Jakobsson M; Jurvelin J; Kairemo K; Kumpulainen E; Kulmala J J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):123-7. PubMed ID: 7543288 [TBL] [Abstract][Full Text] [Related]
13. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease. Brenner W; Kampen WU; Kampen AM; Henze E J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521 [TBL] [Abstract][Full Text] [Related]
14. Timing and optimized acquisition parameters for the whole-body imaging of ¹⁷⁷Lu-EDTMP toward performing bone pain palliation treatment. Liu C; Brašić JR; Liu X; Li H; Xiang X; Luo Z; Wang Y; Kuai D; Zhang G; Zaknun JJ Nucl Med Commun; 2012 Jan; 33(1):90-6. PubMed ID: 22001721 [TBL] [Abstract][Full Text] [Related]
15. The impact of different bone tracers and acquisition times on image quality of equine bone scintigraphy. Mageed M; Dyab S; Swagemakers JH; Gerlach K Vet Radiol Ultrasound; 2022 Sep; 63(5):593-600. PubMed ID: 35666549 [TBL] [Abstract][Full Text] [Related]
16. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate]. Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135 [No Abstract] [Full Text] [Related]
17. Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)? Frühling J; Verbist A; Balikdjian D Nucl Med Commun; 1986 Jun; 7(6):415-25. PubMed ID: 3748485 [TBL] [Abstract][Full Text] [Related]
19. Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake. Bach-Gansmo T; Wien TN; Løndalen A; Halvorsen E Clin Physiol Funct Imaging; 2016 May; 36(3):237-41. PubMed ID: 25524030 [TBL] [Abstract][Full Text] [Related]
20. The visualization of femoral vessels in delayed bone scans--a sign of arteriosclerosis? A comparison of 99mTc-MDP and 99mTc-DPD. Lantto T; Järvi K; Toivio I; Vähätalo S; Vorne M Eur J Nucl Med; 1989; 15(5):265-8. PubMed ID: 2759127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]